Philips(US:PHG) Globenewswire·2025-11-30 17:00Core Insights - Royal Philips has launched Verida, the world's first detector-based spectral CT fully powered by AI, marking a significant advancement in CT technology [1][6] - The integration of AI optimizes the imaging chain, resulting in lower system noise, improved image quality, and faster clinical workflows [1][3] Company Overview - Royal Philips is a global leader in health technology, focusing on improving health and well-being through innovation [13][14] - The company generated sales of EUR 18 billion in 2024 and employs approximately 67,000 people across more than 100 countries [14] Product Features - Verida features AI-driven spectral precision, enabling superior image quality and accelerated scans, fully integrated into radiology workflows [5][6] - The system can reconstruct 145 images per second, allowing for exams to be completed in less than 30 seconds, effectively doubling the speed of previous systems [4][6] - Verida can achieve a dose reduction of up to 80% and reduce energy consumption by up to 45% [3][11] Clinical Impact - The introduction of Verida is expected to enhance diagnostic confidence and reduce the need for invasive procedures, particularly in cardiac imaging [4][5] - The system has been designed to meet the demands of high-throughput environments, allowing up to 270 exams per day [11] Market Position - Philips has pioneered detector-based spectral CT technology, which has been widely adopted in clinical settings, supported by over 800 peer-reviewed publications [2][8] - The company emphasizes that its spectral CT technology has been a reliable clinical tool for over a decade, providing comparable or superior clinical outcomes at a lower total cost of ownership [5][6]